Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas

Journal Article

Full Text

Duke Authors

Cited Authors

  • Wagner, SA; Desjardins, A; Reardon, DA; Marcello, J; II, HJE; Quinn, JA; Rich, JN; Sathornsumetee, S; Friedman, HS; Vredenburgh, JJ

Published Date

  • May 20, 2008

Published In

Volume / Issue

  • 26 / 15

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2008.26.15_suppl.2021